Jiangsu Nanfang Medical (603880) — Net Asset Quality Index
Jiangsu Nanfang Medical (603880) has a Net Asset Quality Index of 19.3% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥912.66 Million minus total liabilities of CN¥736.45 Million yields net assets of CN¥176.20 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check 603880 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Jiangsu Nanfang Medical Net Asset Quality Index Over Time (2012–2025)
This chart shows how Jiangsu Nanfang Medical's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of March 2026, the index stands at 19.3%, representing net assets of CN¥176.20 Million against total assets of CN¥912.66 Million CNY. See 603880 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Jiangsu Nanfang Medical (2012–2025)
The table below presents the year-by-year Net Asset Quality Index for Jiangsu Nanfang Medical from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market cap of Jiangsu Nanfang Medical.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 19.5% | CN¥181.17 Million | CN¥927.94 Million | CN¥746.77 Million | ▼ -7.4 pp |
| 2024 | 26.9% | CN¥284.41 Million | CN¥1.06 Billion | CN¥772.14 Million | ▼ -10.2 pp |
| 2023 | 37.1% | CN¥474.22 Million | CN¥1.28 Billion | CN¥803.11 Million | ▼ -5.5 pp |
| 2022 | 42.6% | CN¥621.48 Million | CN¥1.46 Billion | CN¥835.75 Million | ▼ -10.4 pp |
| 2021 | 53.0% | CN¥654.90 Million | CN¥1.24 Billion | CN¥580.29 Million | ▼ -12.3 pp |
| 2020 | 65.3% | CN¥700.80 Million | CN¥1.07 Billion | CN¥371.84 Million | ▲ +0.1 pp |
| 2019 | 65.3% | CN¥567.52 Million | CN¥869.60 Million | CN¥302.08 Million | ▼ -1.0 pp |
| 2018 | 66.2% | CN¥560.04 Million | CN¥845.81 Million | CN¥285.78 Million | ▲ +0.9 pp |
| 2017 | 65.3% | CN¥537.57 Million | CN¥822.96 Million | CN¥285.40 Million | ▲ +15.6 pp |
| 2016 | 49.7% | CN¥256.69 Million | CN¥516.55 Million | CN¥259.87 Million | ▲ +2.7 pp |
| 2015 | 47.0% | CN¥222.51 Million | CN¥473.37 Million | CN¥250.86 Million | ▼ -1.3 pp |
| 2014 | 48.3% | CN¥210.90 Million | CN¥437.01 Million | CN¥226.10 Million | ▲ +3.1 pp |
| 2013 | 45.2% | CN¥168.57 Million | CN¥373.35 Million | CN¥204.78 Million | ▲ +13.2 pp |
| 2012 | 32.0% | CN¥121.38 Million | CN¥379.79 Million | CN¥258.41 Million | — |